funding gap emerging markets
Mongolie

Bambaipharma LLC 2

  • Golomt Bank
  • Investissement via un partenaire local
  • + 62 autres investisseurs
  • With the second loan amount of EUR 42,000 the company will be able to purchase the needed medication for the second branch.

    42 000 €
    Montant
    3,00%
    Intérêt
    36 mois
    Maturité
    6 mois
    Remboursements
    EUR
    Devise
    Montant42 000 €
    Intérêt3,00%
    Maturité36 mois
    Remboursements6 mois
    DeviseEUR
      100%
      Entièrement financé en 3 jours sur 3 Avril 2019.
      Choisir le montant
      Investir à partir de 50 €
      Investissement moyen
      Basé sur l'historique de tous les investissements sur Lendahand
      Financement complet
      Le projet sera entièrement financé

      Résumé

      “Bambaipharma” pharmacy was founded in 1998 by business partners Baigalmaa and Ichinkhorol. The founder Baigalmaa has been graduated as a pharmacist in Irkutsk city of Russia in 1985. She worked in a pharmaceutical company of Erdenet city for 13 years. Having a good work experience in a drug supplier company, she established her own company “Bambaipharma” with her business partner. Later in 2008, the company was expanded into an official pharmaceutical company and operates as one of the main drug wholesale company of the city. Now, the company has 8 employees and successfully operates in 2 branches.

      “Bambaipharma” pharmacy has been operating in Erdenet city for almost 20 years, and the company has been renowned for reliable medicines among the local citizens. Therefore, the company aspires to increase the inventory by importing medicines. The company plans to purchase pain killer ointments, nasal and eye drops, and variety of other medicines.

      Nom de l’entrepriseBambaipharma LLC 2
      PDGBaigalmaa Jamyandorj
      Création1998-02-22
      LieuErdenet city
      SecteurWholesale / Retail
      Chiffre d'affaires350 932,58 €
      Employés8

      Impact

      Small and Medium Enterprises (SMEs) are important contributors to job creation and economic growth in emerging markets. However, access to financing is a key constraint to SME growth, as about half of them don't have access to formal credit. In Mongolia, Golomt Bank serves nearly 80% of the corporate market. They were the first commercial bank in the country to issue small business loans. Golomt Bank accelerated the development of mobile banking in Mongolia by introducing smart banking services in the local financial sector.

      Financial support enables Mongolian entrepreneurs to increase their professional activity, resulting in job creation and improved living conditions.

      Golomt Bank is a member of the United Nations Environmental Program Finance Initiative (UNEP FI). This partnership helps create a financial sector that serves people and the planet and mobilizes private sector finance for sustainable development. The bank has a "Sustainable Development Policy" in which they implement the SDGs in all its operations. For example, improving their waste management, increasing the number of roads for wheelchair users in their offices, and cooperating with environmentally friendly organizations.

       

      SDGs impacted

      With this project you are contributing to the following Sustainable Development Goals:

      SDG 1. No Poverty

      SDG 8. Decent work and economic growth

      Read more about the impact you can make through our platform and the SDGs on our impact page.

       

      Related blog posts

      Read more about other Microfinance Institutions in our portfolio in this overview.

      • Grâce à cet investissement 2 emplois sont créés
      • Avec cet investissement 10 sont améliorées

      Pardon! Vous devez être connecté pour voir cette page.

      Pardon! Vous devez être connecté pour voir cette page.

      Pardon! Vous devez être connecté pour voir cette page.

      Pardon! Vous devez être connecté pour voir cette page.

      Pardon! Vous devez être connecté pour voir cette page.

      Nous avons déjà contribué à Bambaipharma LLC 2

      Bas Schipper
      Jan Okken
      Ton Schroer
      Jan Mostert
      Marc Sierink
      + et autre
      62
      investisseurs